Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 33, Issue 12, Pages 2558-2567
Publisher
Oxford University Press (OUP)
Online
2012-10-02
DOI
10.1093/carcin/bgs285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
- (2011) Orit Leshem et al. PLoS One
- Molecular classification of prostate cancer using curated expression signatures
- (2011) E. K. Markert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- Inhibition of integrin-linked kinase blocks podocyte epithelial–mesenchymal transition and ameliorates proteinuria
- (2010) Young Sun Kang et al. KIDNEY INTERNATIONAL
- Snail1 is over-expressed in prostate cancer
- (2009) SARA HEEBØLL et al. APMIS
- LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
- (2009) Y. Li et al. CANCER RESEARCH
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Type I collagen promotes epithelial–mesenchymal transition through ILK-dependent activation of NF-κB and LEF-1
- (2009) Damian Medici et al. MATRIX BIOLOGY
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
- (2009) Jennifer C King et al. NATURE GENETICS
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
- (2008) Liesel M FitzGerald et al. BMC CANCER
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
- (2008) B. C. Fuchs et al. CANCER RESEARCH
- Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
- (2008) R. Mehra et al. CANCER RESEARCH
- Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer
- (2008) B. E. Helgeson et al. CANCER RESEARCH
- Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
- (2008) Y. Hu et al. CLINICAL CANCER RESEARCH
- Integrin-linked kinase regulates E-cadherin expression through PARP-1
- (2008) Timothy R. McPhee et al. DEVELOPMENTAL DYNAMICS
- Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization
- (2008) Andrew B. Fielding et al. JOURNAL OF CELL BIOLOGY
- Integrin-linked kinase - essential roles in physiology and cancer biology
- (2008) P. C. McDonald et al. JOURNAL OF CELL SCIENCE
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
- TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
- (2008) C Sun et al. ONCOGENE
- A causal role for ERG in neoplastic transformation of prostate epithelium
- (2008) O. Klezovitch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
- ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer
- (2007) David P Turner et al. Expert Review of Anticancer Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started